Potentially suboptimal medicine regimens among older adults https://t.co/is8zcWJJC3 https://t.co/lTLI4aeDoO https://t.co/YW4lb4KtUb https://t.co/STMN0KMYPH https://t.co/7HbcXXv3uK https://t.co/kj8jMdol8k https://t.co/k06UcYJfTa https://t.co/jutMhM933K https://t.co/FDTLlrjAPc https://t.co/weDYqnsi9L
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Oct 2014 – Jun 2023Where it's discussed
-
X / Twitter49 posts
-
News11 articles
-
Facebook4 posts
-
YouTube3 videos
-
Reddit3 posts
-
Blogs2 articles
AI synopsis
What people are saying
The overall discussions focus on the review of deprescribing's role in reducing medication issues among older adults, with mentions of tailored interventions and fall prevention. The tone is informational and cautious, emphasizing potential benefits without strong endorsement, which explains the neutral agreement and moderate engagement levels. For example, phrases like 'proving a popular read' and references to 'potentially suboptimal regimens' show a focus on ongoing debates and practical considerations.
The discussions mention the systematic review and its findings but do not show strong agreement or disagreement, indicating a neutral stance overall.
While there is some interest in deprescribing and its benefits, the level of engagement suggests moderate curiosity rather than deep investment.
Posts reference specific topics like individual interventions and medication regimens, demonstrating some engagement in the details, but not in-depth analysis.
The discussions reflect an awareness of the findings without suggesting a significant or transformative impact, leaning toward cautious recognition.
Abstract in brief
- Deprescribing, which involves reducing inappropriate medications in older adults, has been studied to see if it improves health outcomes and reduces mortality.
- The review found that deprescribing significantly decreased mortality in nonrandomized studies and when patient-specific interventions were used in randomized trials, but overall it did not show a clear mortality benefit in all randomized studies.
- The findings suggest that deprescribing might be safe and potentially beneficial, especially when tailored to individual patients, though more consistent evidence from randomized controlled trials is needed.
Top posts
Most liked on X and Bluesky#Deprescribbing psychotropic medications can reduce the number of falls (does not seem to reduce number of fallers) with a relative attributable risk of 0.34 (95% CI 0.61-0.73) https://t.co/a0gGeyjQa5 or https://t.co/OvGpFraezw
Deprescripción en personas mayores: mejor intervenciones individualizadas con los pacientes, que programas formativos
BPS Publications https://t.co/1Hiw3TfLAL #deprescribing
RT @AmyTPage: Potentially suboptimal medicine regimens among older adults https://t.co/is8zcWJJC3 https://t.co/lTLI4aeDoO https://t.co/YW4…
RT @AmyTPage: #deprescribing #polypharmacy #PIMS https://t.co/FZ6hpBNfHB https://t.co/gDfCSjYXOH https://t.co/Dzk0fuCQ4h https://t.co/3dxWi…
All mentions
Polypharmacy in Older Australians: Trends and Implications
This video discusses the prevalence of polypharmacy among Australians aged 70 and older, highlighting that in 2017, 36.1% were affected. As polypharmacy increases, so do concerns over the potential harm associated with…
Prevalence of Polypharmacy in Older Australians (2006-2017)
This video explores the prevalence of polypharmacy among Australians aged 70 and older from 2006 to 2017. Notably, in 2017, 36.1% of this demographic experienced continuous polypharmacy, indicating significant health…
Impact of Deprescribing on Older Adults' Health Outcomes
This video discusses the potential effects of deprescribing in older adults, focusing on its feasibility and impact on mortality and health. It reviews key findings from systematic research and meta-analysis aimed at…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @AmyTPage: #deprescribing #polypharmacy #PIMS https://t.co/FZ6hpBNfHB https://t.co/gDfCSjYXOH https://t.co/Dzk0fuCQ4h https://t.co/3dxWi…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @BritPharmSoc: .@BritJClinPharm systematic review from @uwanews on #deprescribing proving a popular read https://t.co/8kSkmDWJAn https:/…
RT @AmyTPage: #deprescribing #polypharmacy #PIMS https://t.co/FZ6hpBNfHB https://t.co/gDfCSjYXOH https://t.co/Dzk0fuCQ4h https://t.co/3dxWi…
Deprescripción en personas mayores: mejor intervenciones individualizadas con los pacientes, que programas formativos
RT @AmyTPage: Potentially suboptimal medicine regimens among older adults https://t.co/is8zcWJJC3 https://t.co/lTLI4aeDoO https://t.co/YW4…
Potentially suboptimal medicine regimens among older adults https://t.co/is8zcWJJC3 https://t.co/lTLI4aeDoO https://t.co/YW4lb4KtUb https://t.co/STMN0KMYPH https://t.co/7HbcXXv3uK https://t.co/kj8jMdol8k https://t.co/k06UcYJfTa https://t.co/jutMhM933K https://t.co/FDTLlrjAPc https://t.co/weDYqnsi9L
#Deprescribbing psychotropic medications can reduce the number of falls (does not seem to reduce number of fallers) with a relative attributable risk of 0.34 (95% CI 0.61-0.73) https://t.co/a0gGeyjQa5 or https://t.co/OvGpFraezw
BPS Publications https://t.co/1Hiw3TfLAL #deprescribing